ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	13/228	79/7206	9.37415656144e-07
ko00643	Styrene degradation	4/228	4/7206	9.7686893632e-07
ko04060	Cytokine-cytokine receptor interaction	20/228	191/7206	2.21021126009e-06
ko04666	Fc gamma R-mediated phagocytosis	15/228	122/7206	6.10950805611e-06
ko05131	Shigellosis	11/228	82/7206	4.83172650146e-05
ko00350	Tyrosine metabolism	7/228	33/7206	6.12413863445e-05
ko04974	Protein digestion and absorption	11/228	96/7206	0.000206201064511
ko04510	Focal adhesion	18/228	240/7206	0.000565490215555
ko04810	Regulation of actin cytoskeleton	19/228	264/7206	0.000838340985795
ko04668	TNF signaling pathway	11/228	120/7206	0.00139563881712
ko05133	Pertussis	9/228	87/7206	0.00162742641247
ko05132	Salmonella infection	9/228	98/7206	0.00369997727094
ko05100	Bacterial invasion of epithelial cells	9/228	99/7206	0.00396077816646
ko05410	Hypertrophic cardiomyopathy (HCM)	9/228	100/7206	0.00423576360911
ko04657	IL-17 signaling pathway	8/228	87/7206	0.00604773351253
ko05145	Toxoplasmosis	10/228	126/7206	0.0064396640267
ko00980	Metabolism of xenobiotics by cytochrome P450	5/228	40/7206	0.00809393761598
ko05134	Legionellosis	7/228	74/7206	0.00861494064411
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2/228	5/7206	0.00935763566617
ko00565	Ether lipid metabolism	5/228	42/7206	0.00994411881958
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	7/228	79/7206	0.0121573649492
ko00512	Mucin type O-glycan biosynthesis	4/228	29/7206	0.0124527464074
ko00564	Glycerophospholipid metabolism	8/228	99/7206	0.0128440578997
ko05146	Amoebiasis	8/228	99/7206	0.0128440578997
ko00360	Phenylalanine metabolism	3/228	17/7206	0.0153103229233
ko05016	Huntington's disease	1/228	215/7206	0.0154792861631
ko04621	NOD-like receptor signaling pathway	11/228	157/7206	0.0169272243416
ko05204	Chemical carcinogenesis	5/228	48/7206	0.017188797024
ko04611	Platelet activation	11/228	163/7206	0.01908690112
ko05164	Influenza A	11/228	167/7206	0.0210135987746
ko05222	Small cell lung cancer	7/228	89/7206	0.0222037050513
ko00590	Arachidonic acid metabolism	5/228	52/7206	0.0235810309877
ko00120	Primary bile acid biosynthesis	3/228	20/7206	0.0239453970977
ko00740	Riboflavin metabolism	2/228	8/7206	0.0246078801465
ko00982	Drug metabolism - cytochrome P450	4/228	37/7206	0.0284777326805
ko04670	Leukocyte transendothelial migration	10/228	151/7206	0.0285922614094
ko00480	Glutathione metabolism	5/228	55/7206	0.0292661640016
ko05160	Hepatitis C	10/228	153/7206	0.0299205118871
ko04080	Neuroactive ligand-receptor interaction	6/228	423/7206	0.0310541044789
ko04728	Dopaminergic synapse	1/228	185/7206	0.0315644357536
ko00540	Lipopolysaccharide biosynthesis	1/228	1/7206	0.0316402997502
ko00626	Naphthalene degradation	1/228	1/7206	0.0316402997502
ko00401	Novobiocin biosynthesis	1/228	1/7206	0.0316402997502
ko05130	Pathogenic Escherichia coli infection	6/228	77/7206	0.0345089788958
ko04380	Osteoclast differentiation	9/228	134/7206	0.0388365102918
ko04623	Cytosolic DNA-sensing pathway	4/228	41/7206	0.0396272484501
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/228	11/7206	0.0454201195544
ko04723	Retrograde endocannabinoid signaling	1/228	175/7206	0.0457799330537